Carl Sailer is Director of Acurx Pharmaceuticals, Inc.. Currently has a direct ownership of 112,552 shares of ACXP, which is worth approximately $151,945. The most recent transaction as insider was on Jan 19, 2024, when has been sold 19,737 shares (Common Stock) at a price of $3.55 per share, resulting in proceeds of $70,066. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 113K
0% 3M change
21.26% 12M change
Total Value Held $151,945

Carl Sailer Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 19 2024
BUY
Exercise of conversion of derivative security
$70,066 $3.55 p/Share
19,737 Added 14.92%
112,552 Common Stock
Jul 27 2022
BUY
Open market or private purchase
$75,001 $3.8 p/Share
19,737 Added 17.54%
92,815 Common Stock
Nov 23 2021
BUY
Open market or private purchase
$24,979 $4.84 p/Share
5,161 Added 6.6%
73,078 Common Stock
Jun 29 2021
BUY
Open market or private purchase
$75,000 $6.0 p/Share
12,500 Added 15.54%
67,917 Common Stock
CS

Carl Sailer

Director
Staten Island, NY

Track Institutional and Insider Activities on ACXP

Follow Acurx Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACXP shares.

Notify only if

Insider Trading

Get notified when an Acurx Pharmaceuticals, Inc. insider buys or sells ACXP shares.

Notify only if

News

Receive news related to Acurx Pharmaceuticals, Inc.

Track Activities on ACXP